C6ORF192 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.571700E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.743800E-01
Normal-vs-Stage2
3.808200E-04
Normal-vs-Stage3
1.528040E-02
Normal-vs-Stage4
2.776000E-02
Stage1-vs-Stage2
1.608000E-01
Stage1-vs-Stage3
1.960410E-01
Stage1-vs-Stage4
3.288400E-01
Stage2-vs-Stage3
2.931400E-01
Stage2-vs-Stage4
6.188800E-01
Stage3-vs-Stage4
6.021800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.366800E-04
Normal-vs-AfricanAmerican
3.094400E-02
Normal-vs-Asian
3.458400E-02
Caucasian-vs-AfricanAmerican
4.914000E-01
Caucasian-vs-Asian
5.597400E-01
AfricanAmerican-vs-Asian
8.573400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.992000E-04
Normal-vs-Female
1.182560E-03
Male-vs-Female
3.577800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.214000E-02
Normal-vs-Age(41-60Yrs)
1.718050E-03
Normal-vs-Age(61-80Yrs)
4.391700E-04
Normal-vs-Age(81-100Yrs)
3.590200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.140200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.558400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.495600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.069000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.055200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.229000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.176500E-03
Normal-vs-Daily Drinker
3.966500E-04
Normal-vs-Weekly Drinker
1.200400E-03
Normal-vs-Occasional Drinker
1.793700E-02
Normal-vs-Social Drinker
3.198900E-03
Non Drinker-vs-Daily Drinker
4.488600E-01
Non Drinker-vs-Weekly Drinker
4.627600E-01
Non Drinker-vs-Occasional Drinker
8.340200E-01
Non Drinker-vs-Social Drinker
7.331400E-01
Daily Drinker-vs-Weekly Drinker
9.199000E-01
Daily Drinker-vs-Occasional Drinker
4.023200E-01
Daily Drinker-vs-Social Drinker
2.712000E-01
Weekly Drinker-vs-Occasional Drinker
4.292600E-01
Weekly Drinker-vs-Social Drinker
2.784000E-01
Occasional Drinker-vs-Social Drinker
9.236400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.964400E-02
Normal-vs-Grade 2
4.080400E-02
Normal-vs-Grade 3
1.009020E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.628400E-01
Grade 1-vs-Grade 3
1.807610E-01
Grade 1-vs-Grade 4
5.964400E-02
Grade 2-vs-Grade 3
5.287600E-01
Grade 2-vs-Grade 4
4.080400E-02
Grade 3-vs-Grade 4
1.009020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.190400E-04
Normal-vs-NonDiabetic
4.783800E-04
Diabetic-vs-NonDiabetic
3.450000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.633300E-04
Normal-vs-NoPancreatitis
3.176300E-04
Pancreatitis-vs-NoPancreatitis
4.108800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.118300E-03
Normal-vs-N1
1.775080E-04
N0-vs-N1
7.213000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.635170E-01
Normal-vs-TP53-NonMutant
4.737900E-02
TP53-Mutant-vs-TP53-NonMutant
3.849500E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
